share

Glycoprotein G, Equid Herpesvirus 4 CAS NO 148349-55-7


Unit Price:

CAS No.:148349-55-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Glycoprotein G, Equid Herpesvirus 4 is a purified viral envelope glycoprotein derived from Equid Herpesvirus 4 (EHV-4), a major causative agent of equine respiratory disease. This highly specific antigen is critical for the development of sensitive and accurate diagnostic assays, enabling the differentiation of EHV-4 from other equine herpesviruses. It is an essential reagent for veterinary diagnostic manufacturers, research institutions, and biopharmaceutical companies focused on equine health, vaccine development, and serological studies.

Application

  • Key Component in ELISA Kits: Serves as the capture or detection antigen in enzyme-linked immunosorbent assay (ELISA) kits for the specific detection of EHV-4 antibodies in equine serum.
  • Lateral Flow Assay Development: Used in the development of rapid point-of-care diagnostic strips for on-site screening of EHV-4 infections.
  • Vaccine Research & Development: Acts as a critical antigen for evaluating immunogenicity and for the development of next-generation subunit or recombinant vaccines against EHV-4.
  • Serological Surveillance: Employed in large-scale seroprevalence studies to monitor the spread and exposure rates of EHV-4 within equine populations.
  • Reference Standard: Functions as a purified reference standard for assay validation, calibration, and quality control in diagnostic laboratories.
  • Antibody Production: Used as an immunogen for the generation of high-affinity monoclonal and polyclonal antibodies specific to EHV-4 Glycoprotein G.

Basic Information

Product Name Glycoprotein G, Equid Herpesvirus 4
CAS No. 148349-55-7
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms EHV-4 Glycoprotein G; Equid Herpesvirus 4 gG; EHV-4 gG Antigen; Equine Rhinopneumonitis Virus Glycoprotein G; Herpesvirus Equid 4 Glycoprotein G; EHV-4 Envelope Glycoprotein; Viral Antigen for EHV-4 Diagnosis
EINECS Contact for details

Quality Control

Our Glycoprotein G, Equid Herpesvirus 4 is produced under stringent conditions to ensure batch-to-batch consistency and high biological activity. Each lot undergoes comprehensive analytical testing, including purity assessment, specificity verification, and functional activity testing in relevant immunoassays. Certificates of Analysis (COA) detailing purity, concentration, and performance data are provided with every shipment.

Storage

Preserve in a tightly closed container at -20°C or below. For long-term storage, aliquot to avoid repeated freeze-thaw cycles and store at -70°C. This product is light-sensitive and should be protected from light exposure. Handle using aseptic techniques to maintain sterility and prevent contamination.

Specification

Item Specification
Appearance Clear to slightly opalescent solution
Purity (SDS-PAGE) ≥ 90%
Protein Concentration ≥ 1.0 mg/mL
Buffer PBS, pH 7.4
Endotoxin Level < 1.0 EU/mg
Sterility Sterile filtered (0.2 µm)
Specificity (ELISA) Reactive with EHV-4 positive serum; minimal cross-reactivity with EHV-1
Functional Activity Suitable for use in ELISA and immunoblot applications

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.